Levothyroxine Sodium Tablet
Product Images NDC 68071-2531

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 68071-2531). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2531 9)

Pdp (68071 2531 9)
Label for Levothyroxine Sodium 125 mcg tablets by NuCare Pharmaceuticals, Inc., listing 90 tablets per container. It includes the NDC 68071-2531-9, instructions to take the medication three times a day, a warning to keep out of reach of children, and storage instructions at controlled temperature 68-77°F. The label also shows manufacturing and packaging information from Intas Pharmaceuticals Limited, India.*
FDA Label Image

Description (Levothyroxine Str)

Description (Levothyroxine Str)
Chemical structure of Levothyroxine Sodium, showing iodine-substituted phenol rings linked by an ether bond and an amino acid side chain containing an amino group, carboxylate, and variable hydration (xH2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.